Biohaven presents at J.P. Morgan Healthcare Conference; pipeline updates expected

Biohaven Ltd.

CEO Vlad Coric presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
Presentation likely covers clinical trial progress for OCD and other pipeline programs.
No specific financial or clinical data disclosed in the exhibit text provided.
Form 8-K furnishes the presentation as Exhibit 99.1 under Regulation FD.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.